RxDoctor Payments Data

Hasan Aldailami, MD

Vascular Surgery · Scottsdale, AZNPI 1972882637

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 26.6% of the total. 2025 is the largest year on record at $34,789, more than ten times the $935 reported in 2019. Among vascular surgery clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,819in general payments, 2019–2025

Across 270 payments — averaging $203.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$15K
  • Boston Scientific$13K
  • Endologix LLC$7K
  • Imperative Care, Inc$6K
  • Penumbra, Inc.$2K
  • Bard Peripheral Vascular, Inc.$2K
  • plus $9K from 23 others
$86,658in research payments, 2019–2025

Across 16 payments — averaging $5416.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$28K
  • Bard Peripheral Vascular, Inc.$25K
  • Humacyte Global, Inc.$14K
  • Penumbra, Inc.$12K
  • Cagent Vascular Inc$8K

What the payments were for

  • Consulting fees$27,28050%
  • Travel & lodging$8,68116%
  • Food & beverage$18,85834%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,819 in reported general payments places this provider in the 90th percentile of 105 vascular surgery providers in Arizona.

See all vascular surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$140,596
Medicare patients
291
Services billed
672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →